Crispr Therapeutics shares owned by Verition Fund Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Verition Fund Management
from 13F filings
Historical chart of Verition Fund Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Verition Fund Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Verition Fund Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $4.9M | 75k | 64.81 |
| 2025-06-30 | $3.9M | 79k | 48.64 |
| 2025-03-31 | $3.9M | 113k | 34.03 |
| 2024-12-31 | $2.5M | 65k | 39.36 |
| 2024-09-30 | $825k | 18k | 46.98 |
| 2024-06-30 | $593k | 11k | 54.01 |
| 2024-03-31 | $1.5M | 21k | 68.16 |
| 2023-09-30 | $341k | 7.5k | 45.39 |
| 2023-03-31 | $1.2M | 27k | 45.23 |
| 2022-12-31 | $208k | 5.1k | 40.65 |
| 2022-03-31 | $252k | 4.0k | 62.78 |
| 2019-12-31 | $239k | 3.9k | 60.88 |